2 Xideas Ag Cooper Companies, Inc. Transaction History

2 Xideas Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$306.88 - $380.0 $357,515 - $442,700	1,165 Added 3.55%	33,994 $12.9 Million
Q3 2023 Nov 07, 2023	BUY	$315.92 - $397.36 $491,887 - $618,689	1,557 Added 4.98%	32,829 $10.4 Million
Q2 2023 Aug 10, 2023	SELL	$346.15 - $392.09 $246,458 - $279,168	-712 Reduced 2.23%	31,272 $12 Million
Q1 2023 May 11, 2023	BUY	$323.56 - $373.36 $137,513 - $158,678	425 Added 1.35%	31,984 $11.9 Million
Q4 2022 Feb 14, 2023	SELL	$248.67 - $334.17 $66,394 - $89,223	-267 Reduced 0.84%	31,559 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$263.81 - $337.27 $72,811 - $93,086	-276 Reduced 0.86%	31,826 $8.4 Million
Q2 2022 Aug 15, 2022	SELL	$301.4 - $428.42 $1.66 Million - $2.36 Million	-5,516 Reduced 14.66%	32,102 $10.1 Million
Q1 2022 May 16, 2022	BUY	$379.46 - $424.54 $12.1 Million - $13.6 Million	31,952 Added 563.93%	37,618 $15.7 Million
Q4 2021 Feb 14, 2022	BUY	$373.53 - $434.12 $2.12 Million - $2.46 Million	5,666 New	5,666 $2.37 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of 2 Xideas Ag, based on Form 13F filings with the SEC.

Stay updated on 2 Xideas Ag with notifications on news.